HMGB1 and colorectal carcinoma: These findings elucidate the molecular mechanism by which MSI2 regulates the PTMs of HMGB1 to reshape the TIME and reprogram immunometabolism, providing new important insights into the role of MSI2 in CRC immunopathology.